Successful Hemostasis During a Major Orthopedic Operation by Using Recombinant Activated Factor VII in a Patient With Severe Hemophilia A and a Potent Inhibitor
- 31 July 1994
- journal article
- case report
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 69 (7), 641-644
- https://doi.org/10.1016/s0025-6196(12)61340-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Recombinant Activated Factor VII in the Treatment of Bleeding Episodes in Patients With Inherited and Acquired Bleeding DisordersTransfusion Medicine Reviews, 1993
- Complications of Hemophilia A Treatment: Factor VIII InhibitorsaAnnals of the New York Academy of Sciences, 1991
- Factor VIIa in the treatment of haemophiliaBlood Coagulation & Fibrinolysis, 1990
- The Use of Porcine Factor VIII Concentrate (Hyate:C) in the Treatment of Patients With Inhibitor Antibodies to Factor VIIIArchives of Internal Medicine, 1989
- Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIIIBlood, 1983
- Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.JCI Insight, 1983
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Hazards of Prothrombin-Complex Concentrates in Treatment of HemophiliaNew England Journal of Medicine, 1981
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980